{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:30:49Z","timestamp":1778743849230,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.ijantimicag.2008.12.013","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T05:33:22Z","timestamp":1235540002000},"page":"252-254","source":"Crossref","is-referenced-by-count":12,"title":["Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro"],"prefix":"10.1016","volume":"34","author":[{"given":"Francisco Garc\u00eda","family":"L\u00e1zaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Elisa","family":"Rodr\u00edguez-Tarazona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Mu\u00f1oz-Bellido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.12.013_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-117-1-25","article-title":"Treatment of human brucellosis with doxycycline plus rifampicin or doxycycline plus streptomycin. A randomized, double-blind study","volume":"17","author":"Ariza","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib2","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1128\/AAC.39.9.2061","article-title":"Doxycycline\u2013rifampin versus doxycycline\u2013streptomycin in treatment of human brucellosis due to Brucella melitensis The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas","volume":"39","author":"Solera","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199607000-00003","article-title":"Complications associated with Brucella melitensis infections: a study of 530 cases","volume":"75","author":"Colmenero","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucellosis in humans","volume":"20","author":"Ariza","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/AAC.33.8.1409","article-title":"Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis","volume":"33","author":"Khan","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.36.1.150","article-title":"Efficacy of ciprofloxacin for treatment of Brucella melitensis infections","volume":"36","author":"al-Sibai","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/AAC.39.5.1194","article-title":"Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones","volume":"39","author":"Garc\u00eda-Rodr\u00edguez","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.43.9.2337","article-title":"Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis","volume":"43","author":"G\u00fcr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijantimicag.2008.03.012","article-title":"In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA","volume":"32","author":"Turkmani","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00338386","article-title":"Quinolone-resistant mutations of the gyrA gene of Escherichia coli","volume":"211","author":"Yoshida","year":"1988","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/AAC.46.6.1651-1657.2002","article-title":"In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV","volume":"46","author":"Jones","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2004.01.012","article-title":"In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae","volume":"24","author":"Daporta","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/IAI.01349-06","article-title":"The TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence","volume":"75","author":"Posadas","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2008.12.013_bib14","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1128\/AAC.46.9.3050-3053.2002","article-title":"Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family","volume":"46","author":"Braibant","year":"2002","journal-title":"Antimicrob Agent Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T03:55:15Z","timestamp":1558151715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0924857909000247"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.12.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}